Real world experience of trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Andy Cheng, Suzanne Frank, Katherine Baines, Mark Nathan, Rosalie V. Douglas, Rushan Sylva, Jessica Ball, Constantinos Savva, Thomas Talbot, Olga Oikonomidou, Jenny Smith, Alastair Thomson, Felicity Ross, Apostolos Konstantis, Nicola Ainsworth, Pietro Luciano, Pooja Iyer, Shyamika Acharige, Shaikh Rana, Judy King
Institutions: Royal Free London NHS Foundation Trust, The Christie NHS Foundation Trust, Barts Health NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Belfast Health and Social Care Trust, University Hospitals of Leicester NHS Trust, University Hospitals Bristol and Weston NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust, Imperial College Healthcare NHS Trust, NHS Lothian, Western General Hospital, University of Edinburgh, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Cornwall Hospital Trust, Hampshire Hospitals NHS Foundation Trust, Princess Alexandra Hospital NHS Trust, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, Queen Elizabeth Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Portsmouth Hospitals NHS Trust, Worcestershire Acute Hospitals NHS Trust
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399323683
